Hormones by administration
- 1 January 1974
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Effects of 2-Br-α-ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal womenPublished by Elsevier ,1973
- Calusterone (7β,17α-DimethyItestosterone) as Primary and Secondary Therapy of Advanced Breast CancerOncology, 1973
- Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancerPublished by Elsevier ,1972
- Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancerPublished by Elsevier ,1972
- Adrenal function in cancer: Relation to the evolutionPublished by Elsevier ,1971
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- Inhibition of DMBA-Induced Mammary Carcinogenesis in the Rat by 2-Br-α-Ergocryptine (CB 154), An Inhibitor of Prolactin Secretion, and by Nafoxidine (U-11, 100 A), an Estrogen AntagonistGynecologic and Obstetric Investigation, 1971
- Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-α-ergocryptine, a suppressor of lactation and nidationPublished by Elsevier ,1970
- EFFECTS OF CONTINUOUS ORAL ADMINISTRATION OF AQUEOUS DIETHYLSTILBOESTROL SOLUTIONS TO RATSJournal of Endocrinology, 1939
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896